Company Data

Spyre Therapeutics Inc.

Ticker
SYRE
Current Price
$21.29 -5%
Market Cap
$1.1B
Price Target
Refer to Report
Volume
790.1K
52wk Range
$20.07 - $47.97
Advanced Market Data

Overview

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy